New structural information obtained with the relieve of intense X-rays generated by Diamond Light Source,the UK's synchrotron science facility in Oxfordshire, has enabled scientists from Heptares Therapeutics ("Heptares", and the UK-based subsidiary of Sosei Group Corporation) to solve the high-resolution X-ray crystal structure of the glucagon receptor. This biological receptor plays a crucial role in the management of blood glucose levels and is considered to be an principal target for drugs designed to treat metabolic diseases,such as diabetes.
Source: phys.org